Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8
Phase 1
Completed
- Conditions
- Asthma
- Interventions
- Drug: XC8 (histamine glutarimide)Drug: Placebo
- First Posted Date
- 2016-08-29
- Last Posted Date
- 2017-05-18
- Lead Sponsor
- EURRUS Biotech GmbH
- Target Recruit Count
- 32
- Registration Number
- NCT02882217
- Locations
- 🇦🇹
Karl Landsteiner Institut für experimentelle und klinische Pneumologie, Wolkersbergenstraße 1, Wien, Austria
🇩🇪Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM, Feodor-Lynen-Str.15, Hannover, Germany
News
No news found